Engineers Gate Manager’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.93M | Buy |
15,918
+15,557
| +4,309% | +$10.6M | 0.13% | 173 |
|
|
2026
Q1 | $279K | Sell |
361
-9,246
| -96% | -$7.08M | ﹤0.01% | 1739 |
|
|
2025
Q4 | $7.42M | Sell |
9,607
-9,467
| -50% | -$6.43M | 0.09% | 246 |
|
|
2025
Q3 | $10.7M | Sell |
19,074
-10,955
| -36% | -$6.19M | 0.12% | 194 |
|
|
2025
Q2 | $15.8M | Buy |
30,029
+2,695
| +10% | +$1.5M | 0.2% | 127 |
|
|
2025
Q1 | $17.3M | Buy |
27,334
+19,238
| +238% | +$13.2M | 0.29% | 57 |
|
|
2024
Q4 | $5.77M | Sell |
8,096
-7,848
| -49% | -$6.59M | 0.1% | 284 |
|
|
2024
Q3 | $16.8M | Buy |
15,944
+13,626
| +588% | +$15.2M | 0.33% | 43 |
|
|
2024
Q2 | $2.44M | Sell |
2,318
-3,617
| -61% | -$3.51M | 0.05% | 477 |
|
|
2024
Q1 | $5.71M | Buy |
5,935
+5,062
| +580% | +$4.81M | 0.15% | 173 |
|
|
2023
Q4 | $767K | Buy |
873
+310
| +55% | +$255K | 0.02% | 946 |
|
|
2023
Q3 | $463K | Sell |
563
-3,466
| -86% | -$2.72M | 0.02% | 1091 |
|
|
2023
Q2 | $2.89M | Buy |
4,029
+1,038
| +35% | +$800K | 0.11% | 232 |
|
|
2023
Q1 | $2.46M | Buy |
+2,991
| New | +$2.26M | 0.1% | 260 |
|
|
2022
Q4 | – | Sell |
-540
| Closed | -$372K | – | 1976 |
|
|
2022
Q3 | $372K | Sell |
540
-1,986
| -79% | -$1.25M | 0.02% | 985 |
|
|
2022
Q2 | $1.49M | Buy |
2,526
+995
| +65% | +$647K | 0.05% | 470 |
|
|
2022
Q1 | $1.07M | Sell |
1,531
-252
| -14% | -$159K | 0.04% | 615 |
|
|
2021
Q4 | $1.13M | Buy |
+1,783
| New | +$1.1M | 0.05% | 558 |
|
|
2021
Q3 | – | Sell |
-1,354
| Closed | -$756K | – | 1923 |
|
|
2021
Q2 | $756K | Buy |
+1,354
| New | +$686K | 0.05% | 579 |
|
|
2021
Q1 | – | Sell |
-2,113
| Closed | -$1.02M | – | 2078 |
|
|
2020
Q4 | $1.02M | Sell |
2,113
-3,150
| -60% | -$1.7M | 0.04% | 590 |
|
|
2020
Q3 | $2.95M | Buy |
+5,263
| New | +$3.19M | 0.14% | 186 |
|
|
2020
Q2 | – | Sell |
-2,558
| Closed | -$1.25M | – | 1936 |
|
|
2020
Q1 | $1.25M | Sell |
2,558
-16,935
| -87% | -$6.99M | 0.09% | 336 |
|
|
2019
Q4 | $7.32M | Buy |
19,493
+17,995
| +1,201% | +$6.05M | 0.32% | 32 |
|
|
2019
Q3 | $416K | Sell |
1,498
-560
| -27% | -$166K | 0.02% | 862 |
|
|
2019
Q2 | $644K | Buy |
2,058
+1,358
| +194% | +$452K | 0.04% | 640 |
|
|
2019
Q1 | $287K | Buy |
+700
| New | +$288K | 0.02% | 751 |
|
|
2017
Q2 | – | Sell |
-2,850
| Closed | -$1.1M | – | 771 |
|
|
2017
Q1 | $1.1M | Buy |
2,850
+200
| +8% | +$74.1K | 0.11% | 314 |
|
|
2016
Q4 | $973K | Buy |
+2,650
| New | +$1.01M | 0.1% | 331 |
|
|
2016
Q3 | – | Sell |
-6,100
| Closed | -$2.13M | – | 737 |
|
|
2016
Q2 | $2.13M | Sell |
6,100
-861
| -12% | -$332K | 0.15% | 260 |
|
|
2016
Q1 | $2.51M | Buy |
+6,961
| New | +$2.87M | 0.2% | 211 |
|
Other funds holding REGN
Engineers Gate Manager's REGN Position: Q2 2026 in Review
Engineers Gate Manager increased its Regeneron Pharmaceuticals (REGN) stake by 4,309% in Q2 2026, buying an estimated $10.6M and bringing the position to 15,918 shares worth $9.93M. The position accounts for 0.13% of the portfolio, ranked #173.
Engineers Gate Manager first reported a position in REGN in Q1 2016 and has held it in 30 quarters since. The position peaked at $17.3M in Q1 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Engineers Gate Manager held 15,918 shares of Regeneron Pharmaceuticals worth $9.93M as of Q2 2026.
- Engineers Gate Manager bought 15,557 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $10.6M.
- Regeneron Pharmaceuticals made up 0.13% of Engineers Gate Manager's portfolio in Q2 2026, its #173 holding.
- Engineers Gate Manager first reported a position in Regeneron Pharmaceuticals in Q1 2016 and has held it in 30 quarters since.
- Engineers Gate Manager's Regeneron Pharmaceuticals position peaked at $17.3M in Q1 2025.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.